Dr. Dirk Ullmann

Angestellt, Global Head Drug Discovery Services and Managing Director Evotec (München) GmbH, Evotec AG

Neuried, Deutschland

Fähigkeiten und Kenntnisse

Drug Discovery Expertise
Assay Development
High-throughput Screening
Data Management
Structural Biology
Detection Technology
Leadership Expertise
Project Management Track Record
Industrial and Academic Network
Compound Management
Protein chemistry

Werdegang

Berufserfahrung von Dirk Ullmann

  • Bis heute 6 Jahre und 5 Monate, seit Jan. 2018

    Global Head Drug Discovery Services and Managing Director Evotec (München) GmbH

    Evotec AG

    Global Responsibilities for HitID by HT Technologies, Biophysics etc., Protein and Cellular Sciences, Structural Biology, Compound Management, ADME-tox/DMPK and Proteomics.

  • Bis heute 12 Jahre und 9 Monate, seit Sep. 2011

    Executive Vice President Lead Discovery, Managing Director Evotec (München) GmbH

    Evotec AG

    Responsibilities for Proteomics, Structural biology, Biophysics incl. NMR, Biochemical Assays, Screening Operations: Processes: Hit ID, Fragment ID, Hit Triaging, Protein Production, Structural Biology and Structure-Based Drug Design (SBDD), Technology Scouting and Development

  • 2 Jahre und 8 Monate, Jan. 2009 - Aug. 2011

    Chief Scientific Officer (CSO)

    Proteros biostructures GmbH

  • 2 Jahre, Jan. 2007 - Dez. 2008

    Senior Vice President Discovery Biology

    Evotec AG

  • 4 Jahre und 8 Monate, Mai 2002 - Dez. 2006

    Director Biology Services

    Evotec AG

  • 2 Jahre und 5 Monate, Dez. 1999 - Apr. 2002

    Head of Screening Operations

    Evotec AG

  • 1 Jahr und 3 Monate, Okt. 1998 - Dez. 1999

    Section Head Assay Development

    Evotec Biosystems AG

  • 1 Jahr und 1 Monat, Sep. 1997 - Sep. 1998

    Research Scientist New Technologies Physics

    Evotec Biosystems

Ausbildung von Dirk Ullmann

  • 1995 - 1997

    Protein Engineering

    Brandeis University (Waltham, MA, USA)

    Supervisors: Prof. Dr. Lizbeth K. Hedstrom; Prof. Dr. Robert H. Abeles Performed site-directed mutagenesis to explore the structural features which determine the S’ subsite specificity of serine proteases and its proenzymes.

  • 1992 - 1997

    Scientific Assistant

    University of Leipzig

    - Design of proteases and zymogens as new biocatalysts in peptide and protein synthesis - Directed evolution of proteases as restriction proteases and peptide ligases - Conversion of enzyme specificity by protein and substrate engineering - Construction of „substrate mimetics“

  • 2 Monate, Sep. 1991 - Okt. 1991

    Institute of Science and technology

    Universit y of Manchester

  • 1991 - 1994

    Biochemistry

    University of Leipzig

    Solid phase synthesis of a pentapeptide library and their use to explore the S’ subsite specificity of the cysteine protease clostripain

  • 1990 - 1991

    Inorganic Chemistry

    University of Leipzig

    Investigations on the reactivity of dithiocarboxyesters with nucleophiles. Functionalization to derivatives with ligand properties and synthesis of metal complexes.

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Russisch

    Gut

Interessen

Drug Discovery
Structural Biology
Biophysics
Protein Chemistry
Enzymology
Molecular Evolution
Medicinal Chemistry
Structure-guided drug discovery

21 Mio. XING Mitglieder, von A bis Z